ORTHODOSE
source

ORTHODOSE

(72)
Price
Free
Category
Medical
Last update
May 03, 2021
Publisher
Dr Vincent Vandenhaute Contact publisher
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Number of reviews,
total
72
Avg rating,
total
⭐4.6
Loading...

Description

1426 chars

CALCULATOR for RESCUE DOSE and OPIOID CONVERSION. Now available: calculator for opioid rescue dose for daily use in Oncology and Palliative Care with language support for English, Dutch, French, German, Japanese and Spanish. Orthodose also offers a full opioid converter that takes into account alternative ratios from the EBM and a corticoid converter. This mobile application is destined for the treatment of cancer pain in adults. CONTENTS: 1. ORTHODOSE: Calculator for rescue doses 2. OPIOID SWITCHER: Convertor for the following opioids: - MORPHINE: PO, SC, IV - OXYCODONE: PO, SC, IV - HYDROMORPHONE: PO, SC, IV - TAPENTADOL: PO - BUPRENORPHINE: SL , TD , SC , IV - ALFENTANYL: SC, IV - FENTANYL: TD, SC, IV - SUFENTANYL: SC, IV - CODEINE: PO - TRAMADOL: PO - DIHYDROCODEINE: PO - PETHIDINE: PO - HYDROCODONE: PO - DIAMORPHINE: PO, SC, IV 3. CORTICODOSE: Convertor for corticoids 4. ORTHODOSE EBM: Calculator for rescue doses based on the Evidence Based Medicine conversion rate recommendations from the EAPC (Lancet Oncology 2012) IMPORTANT: Opiate conversion ratios must always be adapted to the individual patient. The Orthodose mobile app is not in any way intended to be a substitute for the attending physician responsible for the analgesic treatment prescription. The theoretical data used in the development of Orthodose© refers to the international scientific literature available through April 2013

Screenshots

https://play-lh.googleusercontent.com/fHqXLPxjRcD_gnZjMqAtvgEAfzwxNPtChAJPJKTpCzi0wHce4SznZWirArZT1CkshONa=w720-h310-rwhttps://play-lh.googleusercontent.com/4n71WvLJfpcYSXZ9Oj3uW2S3kS4kXurVkIQb_SQX7qTpXTX77DCBYSgGYUGXpPNflQ=w720-h310-rwhttps://play-lh.googleusercontent.com/JhpXDm-0vyVb2ChHdkb08D4kPev_51KQv5KScgk3-i_HCRqPR2bOI3M76Le_5fm9SOQ=w720-h310-rwhttps://play-lh.googleusercontent.com/jBnWWacT56RZRj5gtkzECUnAYPIE_idl7cal9vKLVTGUvGFF9cfT17EPVbIUi-PeoPo=w720-h310-rwhttps://play-lh.googleusercontent.com/Cq1Tbi_OSpKe_sq7lEYPrGzcbeFhS84I0VpMvXK-70oEhlD-LeblXT-MXBnGXgOEmEFM=w720-h310-rwhttps://play-lh.googleusercontent.com/hCO78q4GaVPDw-MrMSUDLjSwJ0X9NlfMKrNMTnfd_ZAjspfTKRvsRxnIDuZ8-L9mefA=w720-h310-rwhttps://play-lh.googleusercontent.com/fTEf84DljnEKfFn2ayvqXKkxFGvv2Apadj3QLMH7Abt3JtsPra2fWXVZeHro2ymkkfA=w720-h310-rwhttps://play-lh.googleusercontent.com/OksEZxeFHvgpsDeGHRAf-IqpnnfTpUpwUZ44Kw0eCoB7SZiOMfl-RudquPe_NqYN1D4O=w720-h310-rw
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster